Table 1.
Clinicopathological features of gelatinous bone marrow transformation with myeloproliferative disorders
| Case No. | Age/Gender | Initial presentation | The relationship between GMT and myeloproliferative disorders | Cytogenetic analysis | Outcome | Reference |
|---|---|---|---|---|---|---|
| 1 | 48/Male | Pancytopenia and fever | GMT was present 28 months prior to MDS/AML | Monosomy 7 | Died of disease | 5 |
| 2 | 79/Male | Pancytopenia | GMT and acute leukemia simultaneously | Not performed | Died of brain hemorrhage | 6 |
| 3 | 65/Male | Not available | GMT occurred after treatment for MDS | Monosomy 7 | Died of bone marrow failure | 7 |
| 4 | 74/Female | Leukocytopenia | GMT and myelofibrosis simultaneously | Not performed | Died of acute cholecystitis | 8 |
| Present case | 73/Male | Pancytopenia | GMT was present 6 months prior to MDS | del (7q) | Died of pneumonia |
AML, acute myeloid leukemia; GMT, gelatinous bone marrow transformation; MDS, myelodysplastic syndrome.